Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin

Journal of Applied Physiology

Volumn 111, Issue 4, 2011, Pages 1118-1124

  Suda, Koichi ^a   Eom, Jihyoun ^a   Jaw, Jen Erh ^a   Mui, Tammy ^a   Bai, Ni ^a   Or, Chris ^a   Ngan, David ^a   Li, Yuexin ^a   Wang, Xi ^a   Tsuruta, Masashi ^a   Tam, Sheena ^a   Man, S Paul ^a   Van Eeden, Stephan ^a   Sin, Don D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITROPRUSSIDE SODIUM; SIMVASTATIN; VASODILATOR AGENT;

ACUTE LUNG INJURY; ANIMAL; AORTA; ARTICLE; BLOOD; C57BL MOUSE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; DRUG EFFECT; HEART; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG LAVAGE; MALE; METABOLISM; MOUSE; PERMEABILITY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION; VEIN;

ACETYLCHOLINE; ACUTE LUNG INJURY; ANIMALS; AORTA; BRONCHOALVEOLAR LAVAGE FLUID; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; HEART; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; NITROPRUSSIDE; PERMEABILITY; SIMVASTATIN; VASODILATION; VASODILATOR AGENTS; VEINS;

EID: 80054698411     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00158.2011     Document Type: Article

References (50)

1. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 110: 880-885, 2004. (Pubitemid 39096018)
2. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252: 283-294, 2002. (Pubitemid 35253696)
3. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 121: 219-225, 2008. (Pubitemid 351317927)
4. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 121: 1002-1007, 2008.
5. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 17: 773-775, 2003.
6. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 5: E78, 2008.
7. Diomede L, Albani D, Sottocorno M, Donati MB, Bianchi M, Fruscella P, Salmona M. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol 21: 1327-1332, 2001. (Pubitemid 34219840)
8. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. JAMA 279: 1615-1622, 1998. (Pubitemid 28248586)
9. Esteve E, Castro A, López-Bermejo A, Vendrell J, Ricart W, Fernández- Real JM. Serum interleukin-6 correlates with endothelial dysfunction in healthy men independently of insulin sensitivity. Diabetes Care 30: 939-945, 2007. (Pubitemid 46556590)
10. Fessler MB, Young SK, Jeyaseelan S, Lieber JG, Arndt PG, Nick JA, Worthen GS. A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med 171: 606-615, 2005. (Pubitemid 40365416)
11. Gardin JM, Siri FM, Kitsis RN, Edwards JG, Leinwand LA. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Res 76: 907-914, 1995.
12. Garibotto G, Sofia A, Balbi M, Procopio V, Villaggio B, Tarroni A, Di Martino M, Cappelli V, Gandolfo MT, Valli A, Verzola D. Kidney and splanchnic handling of interleukin-6 in humans. Cytokine 37: 51-54, 2007. (Pubitemid 46575287)
13. Giebelen IA, van Westerloo DJ, LaRosa GJ, de Vos AF, van der Poll T. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28: 700-703, 2007. (Pubitemid 350135475)
14. Gompertz S, Bayley DL, Hill SL, Stockley RA. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 56: 36-41, 2001. (Pubitemid 32041717)
15. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J. Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164: 396-402, 2001. (Pubitemid 32778205)
16. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 115: 829-835, 1999. (Pubitemid 29129968)
17. Hollingsworth JW, Chen BJ, Brass DM, Berman K, Gunn MD, Cook DN, Schwartz DA. The critical role of hematopoietic cells in lipopolysaccharide- induced airway inflammation. Am J Respir Crit Care Med 171: 806-813, 2005. (Pubitemid 40562710)
18. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 288: L1026-L1032, 2005. (Pubitemid 40695427)
19. Lefer AM, Campbell B, Shin YK, Scalia R, Hayward R, Lefer DJ. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 100: 178-184, 1999. (Pubitemid 29330017)
20. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417-424, 1994. (Pubitemid 24247397)
21. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 52: 465-477, 1999. (Pubitemid 29278528)
22. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory tract infections and risk of first-time acute myocardial infarction. Lancet 351: 1467-1471, 1998. (Pubitemid 28227037)
23. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with communityacquired pneumonia. Respir Res 6: 82, 2005.
24. Mortensen EM, Pugh MJ, Copeland LA, Restrepo MI, Cornell JE, Anzueto A, Pugh JA. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia. Eur Respir J 31: 611-617, 2008.
25. Mutlu GM, Green D, Bellmeyer A, Baker CM, Burgess Z, Rajamannan N, Christman JW, Foiles N, Kamp DW, Ghio AJ, Chandel NS, Dean DA, Sznajder JI, Budinger GR. Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest 117: 2952-2961, 2007. (Pubitemid 47529625)
26. Nel AE, Strachan AF, Welke HE, de Beer FC. Acute phase response in bronchiectasis and bronchus carcinoma. Respiration 47: 196-200, 1985. (Pubitemid 15085032)
27. Orshal JM, Khalil RA. Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats. Hypertension 43: 434-444, 2004. (Pubitemid 38174151)
28. Orshal JM, Khalil RA. Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 286: R1013-R1023, 2004. (Pubitemid 38661388)
29. Peters TS, Lewis SJ. Lipopolysaccharide inhibits acetylcholine- and nitric oxide-mediated vaso-dilation in vivo. J Pharmacol Exp Ther 279: 918-925, 1996. (Pubitemid 27166868)
30. Piepot HA, Boer C, Groeneveld AB, Van Lambalgen AA, Sipkema P. Lipopolysaccharide impairs endothelial nitric oxide synthesis in rat renal arteries. Kidney Int 57: 2502-2510, 2000. (Pubitemid 30340748)
31. Quartin AA, Schein RMH, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. JAMA 277: 1058-1063, 1997. (Pubitemid 27147544)
32. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767-1772, 2000. (Pubitemid 30213096)
33. Russell JA. Management of sepsis. N Engl J Med 355: 1699-1713, 2006. (Pubitemid 44583960)
34. Saura M, Zaragoza C, Bao C, Herranz B, Rodriguez-Puyol M, Lowenstein CJ. Stat3 mediates interleukin-6 inhibition of human endothelial nitric-oxide synthase expression. J Biol Chem 281: 30057-30062, 2006. (Pubitemid 44537013)
35. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389, 1994.
36. Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol 27: 2576-2581, 2007. (Pubitemid 350158908)
37. Shyamsundar M, McKeown STW, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart C, Backman JT, Elborn JS, McAuley DF. Simvastatin decreases lipopolysaccharide induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 179: 1107-1114, 2009.
38. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: Prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 53: 481-482, 1984. (Pubitemid 14188815)
39. Suda K, Tsuruta M, Eom I, Or C, Mui T, Jaw JE, Li Y, Bai N, Kim J, Man J, Ngan D, Lee J, Hansen S, Lee S, Man SP, Van Eeden S, Sin DD. Acute lung injury induced cardiovascular dysfunction: Effects of IL-6 and budesonide/ formoterol. Am J Respir Cell Mol Biol [Epub ahead of print].
40. Syrjanen J, Valtonen VV, Iivanainen M, Huttunen JK. Preceeding infection as an important risk factor for ischemic brain infarction in young and middle aged patients. BMJ 296: 1156-1160, 1988.
41. Takahashi S, Nakamura H, Seki M, Shiraishi Y, Yamamoto M, Furuuchi M, Nakajima T, Tsujimura S, Shirahata T, Nakamura M, Minematsu N, Yamasaki M, Tateno H, Ishizaka A. Reversal of elastase- induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. Am J Physiol Lung Cell Mol Physiol 294: L882-L890, 2008.
42. Tamagawa E, Suda K, Wei Y, Xing L, Mui T, Li Y, Van Eeden SF, Man SFP, Sin DD. Endotoxin induced translocation of interleukin-6 from lungs to the systemic circulation. Innate Immunity 15: 251-258, 2009.
43. Tamagawa E, Bai N, Morimoto K, Gray C, Mui T, Yatera K, Zhang X, Xing L, Li Y, Laher I, Sin DD, Man SF, van Eeden SF. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J Physiol Lung Cell Mol Physiol 295: L79-L85, 2008.
44. Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sørensen HT. Preadmission use of statins and outcomes after hospitalization with pneumonia: Population-based cohort study of 29,900 patients. Arch Intern Med 168: 2081-2087, 2008.
45. Tsai CT, Lai LP, Kuo KT, Hwang JJ, Hsieh CS, Hsu KL, Tseng CD, Tseng YZ, Chiang FT, Lin JL. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: Implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 117: 344-355, 2008.
46. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31: 391-398, 1998. (Pubitemid 28153460)
47. Valtonen V, Kuikka A, Syrjanen J. Thrombo-embolic complications in bacteraemic infections. Eur Heart J 14, Suppl K: 20-23, 1993. (Pubitemid 24038948)
48. Van de Garde EM, Hak E, Souverein PC, Hoes AW, van den Bosch JM, Leufkens HG. Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 61: 957-961, 2006. (Pubitemid 44787165)
49. Vo PA, Lad B, Tomlinson JA, Francis S, Ahluwalia A. Autoregulatory role of endothelium-derived nitric oxide (NO) on Lipopolysaccharideinduced vascular inducible NO synthase expression and function. J Biol Chem 280: 7236-7243, 2005. (Pubitemid 40341281)
50. Yao HW, Mao LG, Zhu JP. Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury. Clin Exp Pharmacol Physiol 33: 793-797, 2006.